Intangible Assets (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]
Gross Amount	2,147,000	6,506,000
Accumulated Amortization	764,000	3,021,000
Net	1,383,000	3,485,000
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	4 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	20 years
Acquired Customer Base [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Amount	877,000	5,146,000
Accumulated Amortization	409,000	2,646,000
Net	468,000	2,500,000
Acquired Customer Base [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	5 years	5 years
Acquired Customer Base [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years	15 years
Know How [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	15 years	15 years
Gross Amount	512,000	512,000
Accumulated Amortization	213,000	179,000
Net	299,000	333,000
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)		15 years
Gross Amount	339,000	548,000
Accumulated Amortization	0	76,000
Net	339,000	472,000
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	20 years
Gross Amount	159,000
Accumulated Amortization	0
Net	159,000
Biomedical Technologies [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life (years)	5 years	5 years
Gross Amount	260,000	300,000
Accumulated Amortization	142,000	120,000
Net	118,000	180,000